NCT02326922View on ClinicalTrials.gov

The Use of Levonorgestrel-Releasing Device (Metraplant-E) in the Treatment of Dysfunctional Uterine Bleeding

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

March 31, 2016

Conditions
Dysfunctional Uterine Bleeding
Interventions
DEVICE

Metraplant-E levonorgestrel-releasing intrauterine device

Metraplant-E insertion and follow up for 6 months

Trial Locations (1)

Unknown

Ain Shams Maternity Hospital, Cairo

All Listed Sponsors
lead

Ain Shams Maternity Hospital

OTHER

NCT02326922 - The Use of Levonorgestrel-Releasing Device (Metraplant-E) in the Treatment of Dysfunctional Uterine Bleeding | Biotech Hunter | Biotech Hunter